United States · FDA National Drug Code directory
Ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-214_d9b54ffb-864f-1ca8-e053-2995a90a5144
- Product NDC
- 76420-214
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ciprofloxacin
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040609
- Source listing expiry
- 20261231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET, FILM COATED in 1 BOTTLE (76420-214-06) · 76420-214-06
- 10 TABLET, FILM COATED in 1 BOTTLE (76420-214-10) · 76420-214-10
- 14 TABLET, FILM COATED in 1 BOTTLE (76420-214-14) · 76420-214-14
- 20 TABLET, FILM COATED in 1 BOTTLE (76420-214-20) · 76420-214-20
- 30 TABLET, FILM COATED in 1 BOTTLE (76420-214-30) · 76420-214-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →